Company record · JSPR
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.'s interim chief financial officer on the record is Jeet Mahal, effective October 9, 2026, per the filing record.
Tracked changes
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.